Clinical trial
Evaluation of Real World Outcomes With Extended Half-Life Concentrates for Routine Clinical Use in Haemophilia A and B: UK - EHL Outcomes Registry
NCT02938156 is registered in ClinicalTrials.gov with Royal Free Hospital NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Real World Outcomes With Extended Half-Life Concentrates for Routine Clinical Use in Haemophilia A and B: UK - EHL Outcomes Registry
- Lead sponsor
- Royal Free Hospital NHS Foundation Trust
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 17, 2016
- Completion date
- October 31, 2019
- Enrollment
- 500 (estimated)
- Sites
- 21
Conditions
As the registry lists them; a condition with its own page is linked.